schizandrin b has been researched along with fluorouracil in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | schizandrin b (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, M; Dong, B; Feng, Q; He, L; Jiang, L; Jin, R; Qi, Q; Wang, Y; Wu, N | 1 |
1 other study(ies) available for schizandrin b and fluorouracil
| Article | Year |
|---|---|
Schisandrin B suppresses gastric cancer cell growth and enhances the efficacy of chemotherapy drug 5-FU in vitro and in vivo.
Topics: Apoptosis; Cell Line, Tumor; Cyclooctanes; Fluorouracil; Humans; Lignans; Polycyclic Compounds; Stomach Neoplasms | 2022 |